Completed PHASE1 INTERVENTIONAL 2-arm NCT00563992

Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder

Pharmacotherapy of High-Risk Bipolar Disorder

Sponsor: National Institute of Mental Health (NIMH)

Updated 6 times since 2017 Last updated: Apr 30, 2012 Started: Jan 31, 2001 Primary completion: Sep 30, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Bipolar Disorder, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 6 data snapshots since 2001. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States